Location History:
- Fort Worth, TX (US) (2013 - 2017)
- Forth Worth, TX (US) (2018)
Company Filing History:
2 out of 3,923 
1 out of 832,912 Years Active: 2013-2018
Title: David Archer Ellis: Innovator in Ophthalmic Pharmaceuticals
Introduction
David Archer Ellis is a notable inventor based in Fort Worth, TX (US). He has made significant contributions to the field of ophthalmic pharmaceuticals, particularly in the treatment of glaucoma and ocular hypertension. With a total of 3 patents, his work has the potential to impact the lives of many individuals suffering from eye diseases.
Latest Patents
Among his latest patents, Ellis has developed prostaglandin conjugates and derivatives aimed at treating glaucoma and lowering intraocular pressure. These patents disclose methods for their use in ophthalmic pharmaceutical compositions that are effective in treating eye diseases such as glaucoma and elevated intraocular pressure. The compositions comprise an effective amount of the prostaglandin conjugates or derivatives, showcasing Ellis's commitment to advancing medical treatments.
Career Highlights
Throughout his career, David Archer Ellis has worked with prominent companies, including Novartis AG. His experience in the pharmaceutical industry has equipped him with the knowledge and skills necessary to innovate in the field of eye care. His contributions have been recognized and valued in the medical community.
Collaborations
Ellis has collaborated with notable professionals in his field, including Lukas Scheibler and Najam A. Sharif. These collaborations have likely enriched his work and contributed to the development of his innovative patents.
Conclusion
David Archer Ellis stands out as a significant figure in the realm of ophthalmic pharmaceuticals. His innovative patents and collaborations reflect his dedication to improving treatments for glaucoma and ocular hypertension. His work continues to pave the way for advancements in eye care.